TY - JOUR
T1 - Leg metabolism of the amino acids and ammonia in patients with chronic renal failure
AU - Deferrari, G.
AU - Garibotto, G.
AU - Robaudo, C.
AU - Canepa, A.
AU - Bagnasco, S.
AU - Tizianello, A.
PY - 1985
Y1 - 1985
N2 - 1. Leg metabolism of amino acids and ammonia in the postabsorptive state was evaluated in 10 patients with chronic renal failure (CRF) and in 10 patients with normal renal function (controls) by measuring the arterial-femoral venous (A-FV) differences for free amino acids and ammonia. 2. Total amino acid release from the leg and alanine and glutamine release, which accounts for the greatest amount of the total amino acid release, are similar in patients and controls. Total amino acid uptake from the arterial blood and glutamate uptake, which is the amino acid extracted at the highest rate, are comparable in both groups. Taken together these data, in addition to the similarity of A-FV differences for proteolytic markers, namely tyrosine, phenylalanine and histidine, suggest that protein breakdown in peripheral tissues is not increased in patients with CRF. 3. In CRF selective metabolic abnormalities for some amino acids are evident. Whilst only the A-FV differences for valine, leucine, and isoleucine are decreased, additional alterations are observed by relating the A-FV difference for each amino acid to that of proteolytic markers. Such a procedure demonstrates that in CRF histidine release relative to that of proteolytic markers is reduced, whereas proline and arginine release is increased. 4. In CRF the reduced release of some amino acids, mainly branched amino acids, by the leg probably affects the pattern of circulating amino acids. 5. Finally, both in patients and in controls a significant uptake of ammonia is observed; the ammonia uptake is related to arterial levels of this metabolite, confirming the role of peripheral tissues in removing ammonia from circulation.
AB - 1. Leg metabolism of amino acids and ammonia in the postabsorptive state was evaluated in 10 patients with chronic renal failure (CRF) and in 10 patients with normal renal function (controls) by measuring the arterial-femoral venous (A-FV) differences for free amino acids and ammonia. 2. Total amino acid release from the leg and alanine and glutamine release, which accounts for the greatest amount of the total amino acid release, are similar in patients and controls. Total amino acid uptake from the arterial blood and glutamate uptake, which is the amino acid extracted at the highest rate, are comparable in both groups. Taken together these data, in addition to the similarity of A-FV differences for proteolytic markers, namely tyrosine, phenylalanine and histidine, suggest that protein breakdown in peripheral tissues is not increased in patients with CRF. 3. In CRF selective metabolic abnormalities for some amino acids are evident. Whilst only the A-FV differences for valine, leucine, and isoleucine are decreased, additional alterations are observed by relating the A-FV difference for each amino acid to that of proteolytic markers. Such a procedure demonstrates that in CRF histidine release relative to that of proteolytic markers is reduced, whereas proline and arginine release is increased. 4. In CRF the reduced release of some amino acids, mainly branched amino acids, by the leg probably affects the pattern of circulating amino acids. 5. Finally, both in patients and in controls a significant uptake of ammonia is observed; the ammonia uptake is related to arterial levels of this metabolite, confirming the role of peripheral tissues in removing ammonia from circulation.
UR - http://www.scopus.com/inward/record.url?scp=0021867935&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021867935&partnerID=8YFLogxK
U2 - 10.1042/cs0690143
DO - 10.1042/cs0690143
M3 - Article
C2 - 4064563
AN - SCOPUS:0021867935
SN - 0143-5221
VL - 69
SP - 143
EP - 151
JO - Clinical Science
JF - Clinical Science
IS - 2
ER -